Gilead Sciences Insider Trades

GILD

Gilead Sciences (GILD) is a leading biopharmaceutical company based in Foster City, California, dedicated to discovering, developing, and commercializing innovative medicines for life-threatening diseases, including HIV/AIDS, liver diseases, cancer, and inflammatory conditions. The company's leadership includes Chairman and CEO Daniel O'Day, alongside key executives such as Andrew Dickinson (CFO), Flavius Martin (EVP, Research), Johanna Mercier (Chief Commercial Officer), and Merdad Parsey (Chief Medical Officer). The Board of Directors also features prominent individuals like Jacqueline K. Barton and Anthony Welters. Regarding insider trading, activity at Gilead Sciences generally indicates a pattern of more insider selling than buying over recent periods. Executives and directors have engaged in sales of company stock.

Trades Last 12 Months

GILD Price

All Insider Trades for Gilead Sciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mercier Johanna Chief Comm & Corp Aff Officer
Holding Value $19.4M 113,684 shares
Last Trade
Oct 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$469k 3,000 shares
$156.22
$170.68
Dickinson Andrew D Chief Financial Officer
Holding Value $27.5M 161,096 shares
Last Trade
Oct 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$469k 3,000 shares
$156.22
$170.68
O'day Daniel Patrick Chairman & CEO
Holding Value $97.2M 569,683 shares
Last Trade
Oct 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.22M 15,000 shares
$147.90
$170.68
Burkhart Erin Svp, Controllership
Holding Value $248k 1,455 shares
Last Trade
Sep 22, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$117k 768 shares
$152.67
$170.68
Berger Dietmar Chief Medical Officer
Holding Value $3.33M 19,522 shares
Last Trade
Sep 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.1k 263 shares
$144.81
$170.68
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp
Holding Value $1.49M 8,759 shares
Last Trade
Sep 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$41.3k 285 shares
$144.81
$170.68
Welters Anthony Director
Holding Value $951k 5,569 shares
Last Trade
Aug 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.67M 18,000 shares
$148.09
$170.68
Holding Value $1.72M 10,066 shares
Last Trade
Aug 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$725k 5,000 shares
$145.01
$170.68
Horning Sandra Director
Holding Value $1.07M 6,293 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$170.68
Rodriguez Javier Director
Holding Value $2.28M 13,364 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$170.68
Love Ted W Director
Holding Value $936k 5,484 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$170.68
Welters Anthony Director
Holding Value $2.2M 12,894 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$170.68
Manwani Harish Director
Holding Value $2.56M 15,015 shares
Last Trade
Apr 30, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.3k 224 shares
$130.84
$170.68
Holding Value $4.64M 27,202 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$170.68
Kramer Kelly A. Director
Holding Value $3.46M 20,256 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$170.68
O'day Daniel Patrick Chairman & CEO
Holding Value $108M 635,617 shares
Last Trade
Apr 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$895k 6,950 shares
$128.79
$170.68
Telman Deborah H Evp, Corporate Affairs & GC
Holding Value $6.45M 37,799 shares
Last Trade
Nov 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.62M 53,646 shares
$123.40
$170.68
Wilfong Diane E. Interim Corp Controller & CAO
Holding Value $7.95M 46,597 shares
Last Trade
Sep 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$106k 921 shares
$115.25
$170.68
Patterson Sandra Svp, Controllership
Holding Value $1.69M 9,875 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$229k 1,952 shares
$117.21
$170.68
Parsey Merdad Chief Medical Officer
Holding Value $14.1M 82,850 shares
Last Trade
Dec 10, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$164k 1,771 shares
$92.34
$170.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up